Description
Genomic and Precision Medicine (3rd Ed.)
Cardiovascular Disease
Coordinators: Ginsburg Geoffrey S., Willard Huntington F
Language: EnglishSubject for Genomic and Precision Medicine:
Keywords
Acute coronary syndrome (ACS); Adverse responders; Allele; Anticoagulant; Antiplatelet; Antithrombotic; Apolipoprotein; Atherosclerosis; Atrial fibrillation; Beta-myosin heavy chain (MYH7); Biomarkers; Birth defect; Cardiovascular disease; Cardiovascular traits; Cholesterol; Chylomicron; Congenital heart disease; Continuous blood pressure variation; Coronary artery disease; Coronary heart disease; Disease pathology; Dyslipidemia; Echocardiography; Exceptional responders; Exercise; Familial aggregation; Family health history; GWAS; Gene association studies; Gene expression; Gene polymorphism; Gene therapy; Genetic polymorphisms; Genetic testing; Genetic variation; Genetics; Genome wide association studies; Genome-wide association; Genome-wide association studies; Genome-wide association study; Genomewide association study; Genomic methodology; Genomics; Haplotype; Heart failure; Heritability; High-density lipoprotein; Host response; Hypertension; Hypertrophic cardiomyopathy (HCM); Hypertrophy; Insulin resistance; Ion channels; Ischemic stroke; Left ventricular hypertrophy (LVH); Linkage disequilibrium; Lipoprotein; Long-QT syndrome; Low-density lipoprotein; Management; Mendelian; Metabolic syndrome; Modifier gene; Monogenic; Musculoskeletal; Mutation; Myocardial infarction; Myofilament; Myosin binding protein C (MYBPC3); Next-generation sequencing; Obesity; Organ injury; Patient-entered data; Peripheral arterial disease; Personalized medicine; Pharmacodynamics; Pharmacogenetic; Pharmacogenetics; Pharmacogenomics; Pharmacokinetic; Polymorphism; Precision medicine; Prevention; Proarrhythmia; Proteomics; Quantitative trait locus; Review; Risk assessment; Risk genes; Risk prediction; Risk profiling; Sarcomere; Single nucleotide polymorphism; Sudden cardiac death; Sudden cardiac death (SCD); Surgery; Systems medicine; Therapeutic angiogenesis; Torsades de pointes; Triglycerides
Support: Print on demand
Description
/li>Contents
/li>Readership
/li>Biography
/li>Comment
/li>
Genomic and Precision Medicine: Cardiovascular Disease, Third Edition, focuses on the applications of genome discovery on the broad spectrum of cardiovascular disorders. Each chapter is organized for the application of genomics and personalized medicine tools and technologies to a) Risk Assessment and Susceptibility, b) Diagnosis and Prognosis, c) Pharmacogenomics and Precision Therapeutics, and d) Emerging and Future Opportunities in the field.
2. Application of Human Genome Information to Clinical Practice
3. Translating genome information into clinical practice and human health
4. Big Data and Translational Bioinformatics Genomic and Personalized Medicine
5. Health Risk Assessment and Family History
6. Clinical Decision Support
7. Overview of Policy, Ethical and Social Considerations
8. Hypertension
9. Lipoprotein Disorders
10. Coronary Artery Disease and Myocardial Infarction
11. The Vulnerable Plaque and Acute Coronary Syndromes
12. Heart Failure
13. Hypertrophic Cardiomyopathies
14. Arrhythmias
15. Hemostasis and Thrombosis
16. Peripheral Arterial Disease
17. Congenital Heart Disease
18. Perioperative Genomics
19. Stroke
20. Novel Approaches to Cardiovascular Diagnostics
21. Cardiovascular Pharmacogenomics
22. Case Studies
Huntington Willard is on the faculty of the Department of Human Genetics at the University of Chicago. Prior to this appointment, Willard was the President and Director of the Marine Biological Laboratory and Professor of Human Genetics at the University of Chicago. He was previously on the faculty at Duke University, where he was founding director of the university-wide Duke Institute for Genome Sciences & Policy from 2003 to 2014, the Nanaline H. Duke Professor of Genome Sciences, and the Arts & Sciences Professor of Biology & Genome Sciences.
- Presents a comprehensive volume written and edited by cardiovascular genomic specialists
- Covers succinct commentary and key learning points that will assist providers with their local needs for the implementation of genomic and personalized medicine into practice
- Provides an overview on major opportunities for genomic and personalized medicine in practice
- Includes case studies that highlight the practical use of genomics in the management of patients